News
15/04/08

2008 1st quarter sales up 15%

First quarter sales continued to grow at a solid pace

12/03/08

2007 results

Further profit growth; Sales up 16%; Profit before R&D up 19%;

Net profit...

15/01/08

Quarterly information

2007: A further year of strong growth: up 16%

Last update: 20/02/2008

STALLERGENES is a European biopharmaceutical laboratory specialising in the treatment by desensitisation of allergy-related respiratory conditions.

The Group's activities focus on research into allergy, and the development, production and distribution of allergen extracts for the curative treatment of allergic rhinitis and asthma.